Nationally Notifiable Infectious Diseases and Conditions, United States: Annual Tables

TABLE 2b. Annual reported cases of notifiable diseases, by region and reporting area, United States and U.S. Territories, excluding Non-U.S. Residents*, 2019
Data from some jurisdictions may be incomplete due to the coronavirus disease 2019 (COVID-19) pandemic. Please see Note #9 at the bottom of the table.
Reporting Area Arboviral diseases
La Crosse virus disease Powassan virus disease St. Louis encephalitis virus disease West Nile virus disease
Neuroinvasive Non-neuroinvasive Neuroinvasive Non-neuroinvasive Neuroinvasive Non-neuroinvasive Neuroinvasive Non-neuroinvasive
U.S. Residents, excluding U.S. Territories 48 7 39 4 15 2 636 338
New England 1 19 3 3
Connecticut 5 1
Maine 2
Massachusetts 9 2 3
New Hampshire 2
Rhode Island 1 1
Vermont
Middle Atlantic 8 1 1 25 7
New Jersey 4 6 2
New York (excluding New York City) 4 1 6 1
New York City 8 2
Pennsylvania 1 5 2
East North Central 23 7 5 2 40 9
Illinois 22 6
Indiana 4
Michigan 1 11 1
Ohio 19 7 3
Wisconsin 3 5 2 2
West North Central 1 7 1 33 43
Iowa 1 4
Kansas 7 6
Minnesota 1 6 1 2 3
Missouri 4 1
Nebraska 17 11
North Dakota 1 2 7
South Dakota 11
South Atlantic 10 35 10
Delaware
District of Columbia 9 2
Florida 4
Georgia 1 9 5
Maryland 6 1
North Carolina 6 1
South Carolina 2
Virginia 4 2
West Virginia 3
East South Central 13 23 10
Alabama 4 1
Kentucky 1 4 6
Mississippi 12 3
Tennessee 12 3
West South Central 1 48 21
Arkansas 7 2
Louisiana 11 9
Oklahoma 1 6 2
Texas 24 8
Mountain 8 1 273 151
Arizona 8 1 132 42
Colorado 52 70
Idaho 6 8
Montana 3
Nevada 34 12
New Mexico 30 10
Utah 14 7
Wyoming 2 2
Pacific 6 156 84
Alaska 1
California 6 147 78
Hawaii
Oregon 6 3
Washington 3 2
U.S. Territories
American Samoa
Commonwealth of Northern Mariana Islands
Guam
Puerto Rico
U.S. Virgin Islands
  • —: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • U: Unavailable — The data are unavailable.
  • * The 2019 annual tables exclude cases of nationally notifiable conditions and diseases among non-U.S. residents. As a result, data in Table 2 does not include a "Non-U.S. Resident" or "Total" row, that would have been included in the table had the data been stratified into the following four categories, based upon the "country of usual residence" (COUR) algorithm: U.S. Residents, excluding U.S. Territories; U.S. Territories; Non-US. Residents; and Total.Table 2 for the 2019 annual tables only includes the first two of these stratification categories.
  • † To calculate rates, use the populations provided in Table 8. Note that calculation of rates for the following conditions use population subsets presented in Table 8: Zika virus infection, congenital; Zika virus disease, congenital; Infant botulism; Congenital rubella syndrome; Perinatal Hepatitis B infection, Perinatal Hepatitis C infection, Haemophilus influenzae, invasive disease and Invasive pneumococcal disease, and Influenza associated pediatric mortality; see Table 8 (population reference table). Also see notes 3 and 7.